SCHEMBL4757553

SCHEMBL4757553

CCCC(OC(=O)NCC1(OC(C)=O)CCCCC1)OC(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 5/20 0.39
CTSL P07711 4/20 0.39
CTSB P07858 3/20 0.39
LMNA P02545 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SLC6A9 P48067 1/20 0.35
CTSS P25774 1/20 0.34
TP53 P04637 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4754475 0.85 LMNA (0.42) CTSKCTSLCTSBLMNACYP1A2
SCHEMBL3809034 0.85 CTSL (0.32) CTSKCTSLCTSBLMNA
SCHEMBL5145749 0.83 LMNA (0.41) CTSKCTSLCTSBLMNACYP1A2
SCHEMBL4755060 0.83 KMT2A (0.39) CTSKCTSLCTSBLMNACYP1A2
SCHEMBL25400 0.82 LMNA (0.38) CTSKLMNACYP1A2CYP2D6SCN1A
SCHEMBL3818365 0.82 CTSL (0.31) CTSKCTSLCTSB
SCHEMBL3817236 0.82 CTSL (0.31) CTSKCTSLCTSB
SCHEMBL3811678 0.81 LMNA (0.33) CTSKCTSLCTSBLMNA
SCHEMBL3808608 0.80 CTSL (0.30) CTSKCTSLCTSB
SCHEMBL5147240 0.78 ALDH1A1 (0.52) CTSKCTSLCTSBLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008157408-A2 USE OF PRODRUGS OF GABA ANALOGS, ANTISPASTICITY AGENTS, AND PRODRUGS OF GABA B RECEPTOR AGONISTS FOR TREATING SPASTICITY XENOPORT, INC. (US) 2008-12-24 WO disclosed
EP-1404324-A4 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT INC (US) 2004-12-22 EP disclosed
EP-1404324-A2 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF Xenoport, Inc. (US) 2004-04-07 EP disclosed
WO-2002100347-A2 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2002-12-19 WO disclosed